ritalin and tirzepatide A patient on the maximum dose of Adderall (mixed amphetamine salts) 60 mg lost efficacy after starting (Zepbound) and, after switching to Vyvanse (lisdexamfetamine) 30 mg, now reports sleepiness palpitations Eli Lilly's tirzepatide showed positive

Clinical caution: Neither compound is a substitute for a thorough diagnostic workup

Self-reported dose per injection Median bucket: 23 mg Most common: 12 mg Reports span 0 to 5 mg (open-ended top bucket) Anonymized self-reports from PeptIQ users not prescribing guidance

It's important to note that compounded semaglutide should use the base form, not salt forms, as these are not equivalent to FDA-approved semaglutide

Now we know so many health benefits have little to do with that

Clinical trials show tirzepatide produces 22.5% average weight loss compared to semaglutides 14.9%, likely because activating both incretin pathways provides more comprehensive metabolic regulation than activating one pathway alone